Butyrylcholinesterase K variant and Alzheimer’s disease

被引：0

作者：

P. K. Panegyres

Cyril D. S. Mamotte

Sam D. Vasikaran

Steve Wilton

Vicki Fabian

Byron A. Kakulas

机构：

[1] Department of Neuropathology,

[2] Royal Perth Hospital,undefined

[3] Wellington Street,undefined

[4] AUS-Perth 6000,undefined

[5] Australia Fax: +618-92242556,undefined

[6] Department of Clinical Biochemistry,undefined

[7] Royal Perth Hospital,undefined

[8] Wellington Street,undefined

[9] AUS-Perth 6000,undefined

[10] Australia,undefined

[11] Australian Neuromuscular Research Institute,undefined

[12] AUS-Perth 6000,undefined

[13] Australia,undefined

来源：

Journal of Neurology | 1999年 / 246卷

关键词：

Key words Dementia; Genotyping; APOE;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

This study attempted to corroborate findings on the association between butyrylcholinesterase K variant and Alzheimer’s disease. This was performed on an autopsy-confirmed series of patients with Alzheimer’s disease and controls. The butyrylcholinesterase K variant was found to be of increased allele frequency in patients with sporadic Alzheimer’s disease. When related to APOE ɛ4 typing the association was specific but not sensitive for the diagnosis of Alzheimer’s disease.

引用

页码：369 / 370

页数：1

共 50 条

[1] Butyrylcholinesterase K variant and Alzheimer's disease
Panegyres, PK
Mamotte, CDS
Vasikaran, SD
Wilton, S
Fabian, V
Kakulas, BA
[J]. JOURNAL OF NEUROLOGY, 1999, 246 (05) : 369 - 370
[2] The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease
Kehoe, PG
Williams, H
Holmans, P
Wilcock, G
Cairns, NJ
Neal, J
Owen, MJ
[J]. JOURNAL OF MEDICAL GENETICS, 1998, 35 (12) : 1034 - 1035
[3] The butyrylcholinesterase K variant is not associated with Alzheimer's disease
Helbecque, N
Cottel, D
Hermant, X
Guez, D
Amouyel, P
[J]. ALZHEIMERS REPORTS, 1998, 1 (05): : 309 - 313
[4] Butyrylcholinesterase-K variant (BChE-K) and Alzheimer's disease
不详
[J]. CLINICAL BIOCHEMISTRY, 2005, 38 (09) : 856 - 856
[5] Butyrylcholinesterase K Variant and Alzheimer's Disease Risk: A Meta-Analysis
Wang, Zongcheng
Jiang, Yuren
Wang, Xi
Du, Yangsen
Xiao, Dandan
Deng, Youchao
Wang, Jinlian
[J]. MEDICAL SCIENCE MONITOR, 2015, 21 : 1408 - 1413
[6] The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women
Alvarez-Arcaya, A
Combarros, O
Llorca, J
Sánchez-Guerra, M
Berciano, J
Fernández-Viadero, C
Peña, N
[J]. ACTA NEUROLOGICA SCANDINAVICA, 2000, 102 (06): : 350 - 353
[7] No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease
Singleton, AB
Smith, G
Gibson, AM
Woodward, R
Perry, RH
Ince, PG
Edwardson, JA
Morris, CM
[J]. HUMAN MOLECULAR GENETICS, 1998, 7 (05) : 937 - 939
[8] No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese
Lee, DW
Liu, HC
Liu, TY
Chi, CW
Hong, CJ
[J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 96 (02): : 167 - 169
[9] Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease
Raygani, AV
Zahrai, M
Soltanzadeh, A
Doosti, M
Javadi, E
Pourmotabbed, T
[J]. NEUROSCIENCE LETTERS, 2004, 371 (2-3) : 142 - 146
[10] Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland
McIlroy, SP
Crawford, VLS
Dynan, KB
McGleenon, BM
Vahidassr, MD
Lawson, JT
Passmore, AP
[J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 (03) : 182 - 185

← 1 2 3 4 5 →